China SXT Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $29.6M
Liabilities Breakdown FY2023
Total Liabilities: $14.9M
Asset Breakdown
Total Assets: $29.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $17.4M | 58.8% |
| Accounts Receivable | $1.3M | 4.5% |
| Inventory | $531.3K | 1.8% |
| Property, Plant & Equipment | $962.2K | 3.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $27.9K | 0.1% |
| Other Assets | $9.3M | 31.5% |
Liabilities Breakdown
Total Liabilities: $14.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.4M | 9.3% |
| Long-Term Debt | $117.9K | 0.8% |
| Other Liabilities | $13.4M | 89.9% |